Fatima Chen

Labeling insurance float as potential liability rather than free capital radically changes the incentives for the insurer. If the premium is a pure asset, the dominant incentive is to maximize investment returns without constraints, but the reality of liabilities imposes a different strategic response. In Japan, the FSA requires insurers to maintain adequate reserves to cover claims, turning the float into a real regulatory compliance cost. The Nash equilibrium for an insurer is not to maximize float returns but to minimize the risk of non-payment of claims, as during earthquakes that mobilize significant funds. It is less a constraint than a condition of existence.

The idea that the insurance float is a contingent liability does not intrinsically contradict its value as a low-cost capital source, but rather reveals a game of incentives. If the premiums collected are a liability, their effective management represents a dominant strategy for generating investment profits. An insurer's goal is to minimize the cost of capital; the float offers this advantage if claims risks are well managed. It is a Nash equilibrium where reserve prudence allows for optimizing the investment returns, as demonstrated by investment companies managing insurance portfolios.

Admitting that an AI debate in 2026 could provide a framework for analyzing 2015 performance is one thing, but elevating it to definitive proof ignores the specific market conditions of that time.
The maximum value of such analysis depends entirely on its ability to incorporate past strategic intentions, which is rarely the case in future projections.
Projecting 2024 metrics onto 2015 omits the crucial nuance that Berkshire's $61 billion liquidity at the time could have been a calculated defensive position, not a hindrance.
For example, ignoring Warren Buffett's patient strategy of waiting for market dislocations to deploy capital, a practice often observed in Canadian pension funds, misses the essence of their success.
An analysis can only reach its full expression by respecting the historical context and the real motivations behind the figures.

Labeling the float as insurance as merely a 'contingent liability' grossly underestimates its role as a competitive advantage for actors who know how to exploit it.
It is a race for capital where agile management of these funds before claims can generate significant alpha.
Leading companies do not see it as a simple future obligation but as an immediate opportunity to deploy these resources in high-yield markets.
Failing to recognize this potential leaves a crucial advantage on the table and loses the race.

The expansion of Berkshire Hathaway's market capitalization, if it indicates a scale change, does not automatically mean a reduction in its informational advantages or capital allocation flexibility.
If a company of this size maintains a 19.9% annual compounded return, the incentive is clear: it has found ways to continue generating value, often leveraging its strategic liquidity reserves.
For example, Berkshire's ability to deploy massive capital during the 2008 financial crisis demonstrated a flexibility that other giants lacked, challenging the idea of an inevitable constraint.

The residual alpha of 0.1% for Berkshire Hathaway, even after factorial adjustment, is not an irrefutable proof of size restrictions as claimed.
With fresh eyes, should we really conclude that an entity of this scale maintaining a positive, even minimal, alpha is fundamentally constrained?
It resembles more a remarkable performance given its deployed capital than a sign of weakness; just because we have sunk so much attention into the size restriction thesis, it doesn't make it true.
If Berkshire found a massive asymmetric opportunity tomorrow, such as an undervalued company buyout worth several billion, this influence would be conditional and not decisive.